Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenomyosis × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 379 Precursor Cell Lymphoblastic Leukemia-Lymphoma 109 Neoplasms, Plasma Cell 68 Recurrence 59 Lymphoma 52 Leukemia 49 Neoplasms 44 Vomiting 35 Immunoglobulin Light-chain Amyloidosis 33 Burkitt Lymphoma 33 Lymphoma, Mantle-Cell 30 Lymphoma, Large B-Cell, Diffuse 26 Nausea 25 Lymphoma, Non-Hodgkin 24 Breast Neoplasms 22 Waldenstrom Macroglobulinemia 21 Lymphoma, Follicular 21 Leukemia, Lymphocytic, Chronic, B-Cell 19 Hodgkin Disease 19 Prostatic Neoplasms 15 Neoplasm Metastasis 15 Lymphoma, Extranodal NK-T-Cell 15 Leukemia, Myeloid, Acute 15 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14 Amyloidosis 13 Smoldering Multiple Myeloma 12 Lymphoma, B-Cell, Marginal Zone 12 Lung Neoplasms 11 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large-Cell, Immunoblastic 9

Interventions

Uterine Artery Embolization 2 ramosetron 1 Uterine Myomectomy 1 Triamcinolone Acetonide 1 Triamcinolone 1 Surveys and Questionnaires 1 Salpingectomy 1 Saline Solution 1 Iohexol 1 Incidence 1 Ibuprofen 1 High-Energy Shock Waves 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1 Bupivacaine 1 Ascorbic Acid 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02056717 2015-04-17

Use of Dexamethasone in Uterine Artery Embolization

Severance Hospital

Phase NA Completed

Myofibroma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡